Gilead Sciences, Inc. (GIS.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 61.28 |
| Open | 60.94 |
| Bid | 61.44 x 25500 |
| Ask | 61.39 x 20000 |
| Day's range | 60.91 - 61.71 |
| 52-week range | 60.91 - 80.00 |
| Volume | |
| Avg. volume | 950 |
| Market cap | 76.477B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 14.60 |
| EPS (TTM) | 4.20 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.85 (4.65%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
Investor's Business DailyGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
ZacksGilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
- Thomson Reuters StreetEvents
Q1 2024 Gilead Sciences Inc Earnings Call
Q1 2024 Gilead Sciences Inc Earnings Call
© 2024 Yahoo. All rights reserved.